Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aleafia Health Inc ALEAF

Aleafia Health Inc. is a Canada-based cannabis company. The Company offers cannabis products in Canada and destined for international markets, including Australia and Germany. The Company operates a virtual medical cannabis clinic staffed by physicians and nurse practitioners, which provide health and wellness services across Canada. It owns three licensed cannabis production facilities and operates a located distribution center all in the province of Ontario, including an outdoor cannabis cultivation facility in Canada. The Company produces a diverse portfolio of cannabis and cannabis derivative products, including dried flower, pre-roll, milled, vapes, oils, capsules, edibles, sublingual strips, and topicals, for sale in Canada in the medical and adult-use markets, and in select international jurisdictions. Its subsidiaries include Aleafia Inc., Canabo Medical Corporation, Aleafia Farms Inc., Emblem Corp., Emblem Cannabis Corporation, GrowWise Health Limited and other.


GREY:ALEAF - Post by User

Post by sthineion Apr 09, 2021 12:16pm
256 Views
Post# 32966984

I hope so

I hope so

Aphria And Tilray Sparked An M&A Super Cycle And This Is What Comes Next

After Aphria Inc. (APHA.TO) (APHA) and Tilray Inc. (TLRY) announced a merger agreement in late 2020, there has been a substantial increase in the amount of merger and acquisition (M&A) activity in the Canadian cannabis sector.

Yesterday, Canopy Growth Corporation (WEED.TO) (CGC) announced a definitive agreement to acquire Canadian cannabis producer The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) in a transaction that is valued at approx. $435 million on a fully diluted basis.

Going forward, we expect to see Canopy Growth acquire additional assets and highlighted this possibility in an article after it entered into a credit agreement for a US$750 million (USD) senior secured term loan in late March.

The combination of Aphria and Tilray seems to have lit a fire under Canopy Growth and additional Canadian cannabis producers. Canopy Growth’s acquisition comes a few days after Organigram Holdings Inc. (OGI.TO) (OGI) reported an agreement to acquire a cannabis edible brand. We expect Organigram to play a big role in future M&A transactions after it received a C$221 million strategic investment from a wholly-owned subsidiary of British American Tobacco (LSE: BATS) (NYSE:BTI).

Once the merger between Aphria and Tilray is complete, the combined company will be the world’s largest cannabis business and is expected to have a leading position on the international cannabis vertical. From the European Union (EU) to the United States (US), the combined company will have leverage to several strategic emerging international markets, and we are bullish on this aspect of the story.

Canopy Growth’s acquisition of Supreme Cannabis is expected to strengthen its leverage to Canada’s recreational market but will have less of an impact on the international cannabis opportunity.

Through an investment and partnership with Acreage Holdings Inc. (ACRG-AU.CN) (ACRHF), Canopy Growth has attractive leverage to the US market and will be able to capitalize on it when legislation permits.

Several Canadian and us cannabis companies have already acquired assets that are highly levered to the EU. We would not be surprised if Canopy Growth acquired assets that provide additional exposure to the EU and will monitor how the story advances from here.

Although Canada’s cannabis industry has matured, the global opportunity is still in the early innings and we expect the industry to record explosive growth over the next decade.

<< Previous
Bullboard Posts
Next >>